Literature DB >> 25413432

A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer.

Eric A Mellon1, Khosrow Javedan1, Tobin J Strom1, Eduardo G Moros1, Matthew C Biagioli1, Daniel C Fernandez1, Stu G Wasserman1, Richard B Wilder2.   

Abstract

PURPOSE: To compare variable dose-rate volumetric modulated arc therapy (VMAT) with 7-field, step-and-shoot intensity modulated radiation therapy (IMRT) in prostate cancer patients treated with a consistent planning target volume (PTV) to a uniform total radiation therapy dose. METHODS AND MATERIALS: We studied 32 patients who received 8100 cGy in 45 daily fractions to their prostate and proximal 1 cm of the seminal vesicles using variable dose rate VMAT (n = 22) or 7-field, step-and-shoot IMRT (n = 10) for intermediate-risk or high-risk prostate cancer between July 2010 and April 2013. In 90% of patients, VMAT was delivered with 2 arcs. To have an unbiased comparison of plan quality, patients who were treated with VMAT were also planned with IMRT and vice versa. Each patient served as his own control for the comparison.
RESULTS: VMAT reduced median radiation beam-on time from 4.3 to 3.4 minutes (P = .03). There was no statistically significant difference in PTV volumes between the VMAT and step-and-shoot IMRT groups (P = .76). VMAT dose distributions were more homogeneous (P = .003). There was no difference between groups with regard to rectal V60, V65, V70, V75, bladder V65, V70, V75, V80, or femoral heads V33.
CONCLUSIONS: Two-arc VMAT resulted in shorter beam-on times and more homogenous dose distributions than 7-field, step-and-shoot IMRT for prostate cancer. With decreased beam-on time, the intrafraction motion during irradiation is reduced, thus improving confidence that the delivered dose distribution agrees with the plan.
Copyright © 2015 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25413432     DOI: 10.1016/j.prro.2014.03.003

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  11 in total

1.  An Evaluation of Robotic and Conventional IMRT for Prostate Cancer: Potential for Dose Escalation.

Authors:  Dilini S Pinnaduwage; Martina Descovich; Michael W Lometti; Badri Varad; Mack Roach; Alexander R Gottschalk
Journal:  Technol Cancer Res Treat       Date:  2016-03-31

2.  Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Authors:  Dorota Maria Borowicz; Agnieszka Skrobała; Marta Kruszyna-Mochalska; Julian Malicki
Journal:  Radiol Oncol       Date:  2022-03-28       Impact factor: 4.214

Review 3.  Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Authors:  Ben G L Vanneste; Evert J Van Limbergen; Emile N van Lin; Joep G H van Roermund; Philippe Lambin
Journal:  Biomed Res Int       Date:  2016-12-28       Impact factor: 3.411

4.  A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.

Authors:  Ming Li; Gao-Feng Li; Xiu-Yu Hou; Hong Gao; Yong-Gang Xu; Ting Zhao
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

5.  Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.

Authors:  Amandeep S Taggar; Darren Graham; Elizabeth Kurien; James L Gräfe
Journal:  J Appl Clin Med Phys       Date:  2017-11-27       Impact factor: 2.102

6.  Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery.

Authors:  Jing Yu; Tao Hu; Yeshan Chen
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Clinical performance of FractionLab in patient-specific quality assurance for intensity-modulated radiotherapy: a retrospective study.

Authors:  Se An Oh; Sung Yeop Kim; Jaehyeon Park; Jae Won Park; Ji Woon Yea
Journal:  J Yeungnam Med Sci       Date:  2021-09-09

8.  Statistical control of processes applied to geometric uncertainties for CTV expansion margins determination in prostate cancer patients treated with VMAT: a prospective study in 57 patients.

Authors:  J Pardo; J González; N Aymar; I Ortiz; B Rodriguez; D Morera; A Guerrero; A M Mena; J Font
Journal:  Clin Transl Oncol       Date:  2020-09-26       Impact factor: 3.405

9.  Candida albicans Osteomyelitis Pubis: The Possible Pathogenic Role of Pelvic Irradiation.

Authors:  Cristiana Iacuzzo; Jacopo Monticelli
Journal:  Case Rep Orthop       Date:  2017-12-03

10.  RapidArc vs Conventional IMRT for Head and Neck Cancer Irradiation: Is Faster Necessary Better?

Authors:  Karim Mashhour; Maha Kamaleldin; Wedad Hashem
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.